Helaina

We are so excited to see all our friends and collegues next week at SupplySide West. 📍 Visit us at Booth #1631 to learn about the benefits of effera™, the first human equivalent lactoferrin. 🔬Discover insights from effera’s™ latest clinical study. 💰Learn about Helaina's $45 million Series B funding to accelerate our commercialization efforts of effera™. 😋Come by the booth for exclusive samples of effera™ and experience its benefits firsthand. 🗓️Don’t miss out—use the link below to book an appointment with our team, or simply stop by Booth #1631 for a chat. https://lnkd.in/dNZEXNpm

PSA from Helaina's Recruiting Team: Many cybercriminals today are using fraudulent job posts and job offers to access personal information. To keep yourself safe, we have a few helpful recommendations: Beware of fraudulent job posts! All official Helaina jobs are posted on our careers site. If you view a job post that isn't listed on our job board (https://lnkd.in/eB6wcQne) or a job posting with a different URL, the post could be a scam. Lookout for fake recruiters! When interacting with a Helaina recruiter, ensure this individual has an official "@myhelaina.com" email address. We do not use any derivatives of this address, such as "@helainadr.com." If someone claims to contact you on behalf of Helaina using a non-Helaina email address, this is a red flag!

We’re thrilled to announce that Helaina has raised a $45 Series B to accelerate the commercialization of bioactive proteins starting with effera™ human lactoferrin. This infusion of new capital marks our next phase of growth and is the result of years of our dedicated team’s work to drive innovation and scientific rigor within nutrition. At this pivotal moment in our journey, we’re proud to partner with Avidity Partners, an investment firm with an outstanding reputation for supporting best-in-class biotech companies rooted in clinically-backed science. To learn more about what we’re building and our commercial launch, check out AgFunder’s piece. https://lnkd.in/erAtXXya

Check out Helaina's market first - effera™ in Nutraceuticals World Learn how effera™ is revolutionizing the functional food and supplement industry as the first-ever human equivalent lactoferrin for food and supplement applications. Clinically studied for safety, quality, and stability, effera™ brings unmatched benefits for immune health, gut function, and active nutrition. https://lnkd.in/ecAQxSqJ

We are headed to SupplySide West 🛩 next month and will be exhibiting for the first time. Use the link below to book a meeting 🗓 and learn about our groundbreaking ingredient effera™ - the first human equivalent lactoferrin available on the market, supported by pre-clinical and clinical studies. Lactoferrin is the most abundant protein found in colostrum which sequesters and delivers iron where it is needed most. effera™ is made from a precision fermentation process which replicates lactoferrin to ensure a highly bioavailable ingredient. Meet with us to learn how effera™ provides health benefits for gut and immune health, women's health, and active nutrition. https://lnkd.in/egqstidT

Our founder, Laura Katz "sat down" with Danielle Masterson from NutraIngredients to discuss our recent launch of effera™ human lactoferrin into the commercial market—a groundbreaking ingredient that closely resembles the native protein found in breast milk. The interview covers our latest research, a double-blind controlled study which measured the body's response to effera™ and the first ever study to compare the immune impact of bovine lactoferrin vs. human lactoferrin. In addition, new research reveals that effera™ digests similarly to breast milk lactoferrin unlike cow’s milk which digests differently. Both effera™ and breast milk lactoferrin remain intact longer during digestion compared to the cow’s milk alternative. Check out the full interview below!

In a recent podcast with Nutritional Outlook, our Founder & CEO, Laura Katz shares how Helaina's cutting-edge technology replicates bioactive proteins to match those in the human body. Tune in to learn how effera™ human lactoferrin can power your next innovative product formulation for food, beverage, and dietary supplement applications.

Our gut and immune white paper 🔬 is here, written by Susan Hewlings and Cassandra Evans Carson Lactoferrin (LF) is a glycoprotein found in various body fluids, including milk with its highest concentration in colostrum. Lactoferrin has remarkable iron-binding properties making it a powerhouse for gut and immune health. LF supports both innate and adaptive immunity by activating immune cells, while also promoting intestinal tissue growth, repair, and homeostasis. Additionally, LF supports the growth of beneficial gut bacteria, such as Bifidobacteria. Its benefits make LF an ideal component for functional foods and dietary supplements. effera™, a human lactoferrin equivalent, offers high bioavailability and low allergenic risk positioning it as an exciting novel ingredient for gut and immune support. Find out more by using the link below to download the white paper. https://lnkd.in/eMT7tpbv Douglas Kalman PhD RD

Helaina has been recognized by Business Insider as one of the 85 Most Promising Startups of 2024. The article focuses on what sets businesses apart 🌟 and highlights Helaina's goal to revolutionize nutrition with bioactive proteins and its flagship product, effera™ human lactoferrin. Marisa Bass, Primary Venture Partners highlights Helaina's tremendous strides, A+ team, and impressive commercial traction. The company's potential for breakthrough success in 2024 is truly exciting. Check out the full list of promising startups below and see how Helaina is making waves in the science world. 🌐

Having our lab right here at home in New York City gives us the ability to efficiently develop new ingredients, allowing us to quickly respond to market demands and consumer needs. We love opening our door to the community - check out our time with Seema Kumar, CEO at Cure.